MAG-DHA

DIETARY_SUPPLEMENT2 trials

Sponsors

SCF Pharma, Université de Sherbrooke

Conditions

Cystic FibrosisPPROM

Phase 2

Pro-resolving Effect of MAG-DHA in Cystic Fibrosis (PREMDIC)

TerminatedNCT02518672

SCF PharmaCystic Fibrosis

Start: 2015-10-31End: 2016-11-30Updated: 2017-10-04

Unknown Phase

Pro-omega-3, Reduction of Inflammation and Modulation of Prematurity

Université de SherbrookePPROM

Start: 2018-12-03End: 2020-05-15Target: 70Updated: 2018-11-20

Related Papers

The Efficacy of MAG-DHA for Correcting AA/DHA Imbalance of Cystic Fibrosis Patients

Marine Drugs2018-05-2618 citations